On May 1st, Nuventra’s Mark Bush PhD, and Intarcia Therapeutics’ Paul L. Feldman PhD, will lead a webinar titled “Addressing the Challenges of Drug Discovery and Delivery for Combination Peptide Therapeutics.”
There has been growing interest and activity in the use of peptide therapeutics to treat a variety of human diseases. This webinar will present approaches to discover, optimize, assess, and deliver combination peptide therapeutics for treatment of metabolic diseases. Additionally, various considerations to deliver peptide combinations for efficient development and optimal patient benefit and adherence will be presented.
The presentation also will cover key pharmacokinetic considerations in the development of peptide drugs with a focus on factors that affect the absorption, distribution, and elimination of peptide drugs.